failed trials

stock image of a glucose meter with a blood strip

Biotech

Rezolute stock sinks 87% as hypoglycemia drug fails ph. 3 test

Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned approval application.

James Waldron Dec 11, 2025 9:45am

long shot miss basketball hoop fail shoot

J&J's anti-tau antibody posdinemab flops in phase 2

Nov 24, 2025 9:40am

arrow miss target fail attempt try

Contineum-J&J drug fails to improve vision in phase 2 MS trial

Nov 20, 2025 5:26pm

Cartoon of businessmen standing around a broken target

BMS-J&J blood thinner fails phase 3, denting blockbuster hopes

Nov 14, 2025 8:10am

A chessboard with blocks that read MA

Neuphoria, reeling from ph. 3 fail, mulls buyout from investor

Nov 11, 2025 8:40am

colorful brain art model

Neurocrine-Takeda psychiatry pact suffers another phase 2 fail

Nov 11, 2025 6:25am